4th Quarter - Report

ADAPTIVE BIOTECHNOLOGIES for ADAPTIVE BIOTECHNOLOGIES

Firm
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6102 and S.3404; The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020; all provisions

LobbyistCovered position, as disclosed
PAMELA LYNN BRADLEY covered legislative branch official

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6102 (116th), S. 3404 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.